In a fecal microbiota transplant pilot clinical trial in volunteers with obesity, BA profiles were modified to match that of the lean donor after 12 weeks, including sustained reduction in taurocholic acid, without any change in BMI (104)
GLP-1
The significant clinical overlap between ME/CFS and PASC has very recently been reviewed here [82], with the hypothesis that both entities may be caused by a chronic state of multisystemic disequilibrium, including endocrinological, immunological, and/or metabolic changes
This study adds to a growing body of evidence suggesting that GLP-1 receptor agonistsmedications originally designed for diabetes and obesitymay have broader neuroprotective effects, said Merrill
Mammals are able to maintain body temperatures higher than the environment temperature (3539 C) through a balance of body heat production and loss 34
The FDA's own summary is blunt: it recommends obtaining medicines only from legal sources within the United States